Drug-device combination products are a special class of drug product with relatively high technical barriers. The research of their generic products has been a hot and difficult issue. However, the success rate of the product development is extremely low. Compared with ordinary dosage forms, human factor should be systematically considered in the development of generic drug-device products. Currently, there is no guideline for human factors engineering research in China. This study conducts a comparative analysis of factors based on the latest guidelines from FDA, such as"Comparative Analyses and Related Comparative Use Human Factors Studies for a Drug-Device Combination Product Submitted in an ANDA: Draft Guidance for Industry ", and "Bridging for Drug-Device and Biologic-Device Combination Products: Draft Guidance for Industry ". Several case studies are applied for the illustration of some key considerations on development of generic drug-device combination products to provide a reference for researchers.
| 科 Family | 属数 Number of genus | 种数 Number of species | 占总种数比例 Percentage of total species (%) | 属 Genus | 种数 Number of species | 占总种数比例 Percentage of total species (%) |
|---|---|---|---|---|---|---|
| 鹅膏菌科Amanitaceae | 2 | 11 | 5.26 | 鹅膏菌属 Amanita | 10 | 4.78 |
| 小菇科 Mycenaceae | 2 | 12 | 5.74 | 丝盖伞属 Inocybe | 5 | 2.39 |
| 多孔菌科 Polyporaceae | 8 | 14 | 6.70 | 蜡蘑属 Laccaria | 5 | 2.39 |
| 红菇科 Russulaceae | 3 | 23 | 11.00 | 小皮伞属 Marasmius | 6 | 2.87 |
| 小菇属 Mycena | 11 | 5.26 | ||||
| 光柄菇属 Pluteus | 5 | 2.39 | ||||
| 红菇属 Russula | 17 | 8.13 | ||||
| 栓菌属 Trametes | 5 | 2.39 |